Eurobio Scientific SA (ALERS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.030x

Based on the latest financial reports, Eurobio Scientific SA (ALERS) has a cash flow conversion efficiency ratio of 0.030x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€5.36 Million ≈ $6.26 Million USD) by net assets (€180.85 Million ≈ $211.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Eurobio Scientific SA (ALERS) liquidity interval to measure how many days the company can operate on defensive assets alone.

Eurobio Scientific SA - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Eurobio Scientific SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eurobio Scientific SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurobio Scientific SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tatry Mountain Resorts a.s. PR:TMR	N/A
Activate Energy Acquisition Corp. Class A Ordinary Share NASDAQ:AEAQ	-0.001x
Dustin Group AB ST:DUST	0.070x
Texas Ventures Acquisition III Corp NASDAQ:TVA	-0.002x
Perma-Pipe International Holdings Inc NASDAQ:PPIH	-0.064x
Liaoning Kelong Fine ChemicalInc SHE:300405	0.005x
Hyundai Cement KO:006390	0.059x
SiS Distribution (Thailand) Public Company Limited BK:SIS	0.126x

Annual Cash Flow Conversion Efficiency for Eurobio Scientific SA (2007–2024)

The table below shows the annual cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see ALERS stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€178.85 Million ≈ $209.10 Million	€16.70 Million ≈ $19.53 Million	0.093x	-38.88%
2023-12-31	€175.17 Million ≈ $204.80 Million	€26.77 Million ≈ $31.29 Million	0.153x	-38.74%
2022-12-31	€172.67 Million ≈ $201.87 Million	€43.07 Million ≈ $50.36 Million	0.249x	-39.36%
2021-12-31	€160.22 Million ≈ $187.32 Million	€65.92 Million ≈ $77.06 Million	0.411x	-19.23%
2020-12-31	€107.84 Million ≈ $126.08 Million	€54.93 Million ≈ $64.22 Million	0.509x	+273.22%
2019-12-31	€36.56 Million ≈ $42.75 Million	€4.99 Million ≈ $5.83 Million	0.136x	+872.96%
2018-12-31	€29.62 Million ≈ $34.63 Million	€-523.00K ≈ $-611.44K	-0.018x	-122.61%
2017-12-31	€31.69 Million ≈ $37.05 Million	€2.48 Million ≈ $2.89 Million	0.078x	+128.78%
2016-12-31	€12.23 Million ≈ $14.29 Million	€-3.32 Million ≈ $-3.88 Million	-0.271x	-158.84%
2015-12-31	€23.31 Million ≈ $27.25 Million	€-2.44 Million ≈ $-2.86 Million	-0.105x	+13.43%
2014-12-31	€27.95 Million ≈ $32.67 Million	€-3.38 Million ≈ $-3.96 Million	-0.121x	+49.18%
2013-12-31	€20.56 Million ≈ $24.04 Million	€-4.90 Million ≈ $-5.73 Million	-0.238x	-31.31%
2012-12-31	€24.50 Million ≈ $28.64 Million	€-4.45 Million ≈ $-5.20 Million	-0.182x	+59.12%
2011-12-31	€13.57 Million ≈ $15.86 Million	€-6.02 Million ≈ $-7.04 Million	-0.444x	-46.82%
2010-12-31	€19.19 Million ≈ $22.44 Million	€-5.80 Million ≈ $-6.78 Million	-0.302x	-14.79%
2009-12-31	€25.46 Million ≈ $29.76 Million	€-6.71 Million ≈ $-7.84 Million	-0.263x	+73.33%
2008-12-31	€9.74 Million ≈ $11.39 Million	€-9.62 Million ≈ $-11.24 Million	-0.988x	-261.60%
2007-12-31	€18.07 Million ≈ $21.12 Million	€-4.93 Million ≈ $-5.77 Million	-0.273x	--

About Eurobio Scientific SA

PA:ALERS France Medical Devices

Market Cap

$261.31 Million

€223.52 Million EUR

Market Cap Rank

#15972 Global

#231 in France

Share Price

€22.20

Change (1 day)

+0.00%

52-Week Range

€20.60 - €25.70

All Time High

€28.88